TABLE 3.
False-positive lymph node characteristics in each study group
| EBUS first | PETCT first | |
| Subjects n | 41 | 57 |
| Size mm | 8.6 (4.5) | 7.4 (2.9) |
| Nodal station | ||
| Paratracheal | 10 (24.4) | 21 (36.8) |
| Subcarinal | 8 (19.5) | 9 (15.8) |
| Hilar/pulmonary | 23 (56.1) | 27 (47.4) |
| Quantitative SUV | ||
| Lymph node | 4.43±1.87 | 4.36±1.72 |
| Primary lesions* | 13.29±7.68 | 8.46±6.51 |
| Qualitative PETCT uptake on clinical interpretation | ||
| Moderate | 31 (75.6) | 39 (68.4) |
| High | 10 (24.4) | 18 (31.6) |
| EBUS-TBNA results | ||
| Lymphocytes | 40 (97.5) | 57 (100) |
| Granuloma | 1 (2.4) | |
| Inconclusive/inadequate | ||
Data are presented as n (%) or mean±sd, unless otherwise stated. EBUS: endobronchial ultrasound; PETCT: positron emission tomography–computed tomography; SUV: standardised uptake value; EBUS-TBNA: endobronchial ultrasound-transbronchial needle aspiration. *: p<0.05.